S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
The Small Biotech Scaring Big Pharma (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
The Small Biotech Scaring Big Pharma (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
The Small Biotech Scaring Big Pharma (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
The Small Biotech Scaring Big Pharma (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
NASDAQ:CCRN

Cross Country Healthcare - CCRN Price Target & Analyst Ratings

$32.34
-1.18 (-3.52%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$31.39
$33.52
50-Day Range
$28.37
$38.10
52-Week Range
$15.26
$40.12
Volume
833,195 shs
Average Volume
637,344 shs
Market Capitalization
$1.21 billion
P/E Ratio
5.36
Dividend Yield
N/A
Price Target
$36.20

Cross Country Healthcare Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 5 Analyst Ratings

Consensus Analyst Price Target

$36.20
11.94% Upside
High Prediction$45.00
Average Prediction$36.20
Low Prediction$27.00
TypeCurrent
12/8/21 to 12/8/22
1 Month Ago
11/8/21 to 11/8/22
3 Months Ago
9/9/21 to 9/9/22
1 Year Ago
12/8/20 to 12/8/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$36.20$35.20$32.50$23.40
Predicted Upside11.94% Upside34.38% Upside62.75% Upside16.79% Upside
Get Cross Country Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CCRN and its competitors with MarketBeat's FREE daily newsletter.


CCRN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CCRN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cross Country Healthcare Stock vs. The Competition

TypeCross Country HealthcareBusiness Services CompaniesS&P 500
Consensus Rating Score
2.60
2.57
2.48
Consensus RatingModerate BuyBuyHold
Predicted Upside11.94% Upside401.59% Upside15.57% Upside
News Sentiment RatingPositive News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
461
66.24%
Underperform Votes
235
33.76%
Avg. Outperform Votes
173
64.07%
Avg. Underperform Votes
97
35.93%
Avg. Outperform Votes
853
68.13%
Avg. Underperform Votes
399
31.87%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/24/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$31.00-11.96%
11/7/2022Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$41.00 ➝ $45.00+38.46%
10/5/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$36.00+7.17%
9/15/2022Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$37.00 ➝ $42.00+46.09%
1/27/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$18.00 ➝ $27.00+50.67%
6/14/2021BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$17.00 ➝ $20.00+14.68%
10/8/2020Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderperform$7.50+11.94%
8/17/2020Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold ➝ Neutral
5/8/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$9.00 ➝ $7.00+18.04%
(Data available from 12/8/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CCRN Price Target - Frequently Asked Questions

What is Cross Country Healthcare's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for Cross Country Healthcare stock is Moderate Buy based on the current 2 hold ratings and 3 buy ratings for CCRN. The average twelve-month price prediction for Cross Country Healthcare is $36.20 with a high price target of $45.00 and a low price target of $27.00. Learn more on CCRN's analyst rating history.

Do Wall Street analysts like Cross Country Healthcare more than its competitors?

Analysts like Cross Country Healthcare more than other Business Services companies. The consensus rating for Cross Country Healthcare is Moderate Buy while the average consensus rating for business services companies is Buy. Learn more on how CCRN compares to other companies.

Do MarketBeat users like Cross Country Healthcare more than its competitors?

MarketBeat users like Cross Country Healthcare more than other Business Services companies. 66.24% of MarketBeat users gave Cross Country Healthcare an outperform vote while business services companies recieve an average of 64.21% outperform votes by MarketBeat users.

Is Cross Country Healthcare being downgraded by Wall Street analysts?

Over the previous 90 days, Cross Country Healthcare's stock had 1 downgrade by analysts.

Does Cross Country Healthcare's stock price have much upside?

According to analysts, Cross Country Healthcare's stock has a predicted upside of 29.78% based on their 12-month price targets.

What analysts cover Cross Country Healthcare?

Cross Country Healthcare has been rated by Barrington Research, Benchmark, Credit Suisse Group, and Truist Financial in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:CCRN) was last updated on 12/8/2022 by MarketBeat.com Staff